These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38885192)

  • 1. Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD.
    Kong Y; Li C; Liu J; Wu S; Zhang M; Allison DB; Hassan F; He D; Wang X; Mao F; Zhang Q; Zhang Y; Li Z; Wang C; Liu X
    PLoS Genet; 2024 Jun; 20(6):e1011309. PubMed ID: 38885192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell analysis characterizes PLK1 as a catalyst of an immunosuppressive tumor microenvironment in LUAD.
    Kong Y; Li C; Liu J; Zhang M; Allison DB; Hassan F; He D; Wang X; Mao F; Zhang Q; Zhang Y; Li Z; Wu S; Wang C; Liu X
    bioRxiv; 2023 Sep; ():. PubMed ID: 37577553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
    Huang Y; Zhang Y; Duan X; Hou R; Wang Q; Shi J
    Thorac Cancer; 2024 Jul; 15(21):1626-1637. PubMed ID: 38886907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of LZTS2 by PLK1 activates the Wnt pathway.
    Liu R; Zhou D; Yu B; Zhou Z
    Cell Signal; 2024 Aug; 120():111226. PubMed ID: 38740232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination.
    Wang Z; Lei Z; Wang Y; Wang S; Wang JP; Jin E; Liu X; Sun R; Zhang HT
    Oncogene; 2024 Jul; 43(28):2215-2227. PubMed ID: 38802647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway.
    Dalvi PS; Macheleidt IF; Lim SY; Meemboor S; Müller M; Eischeid-Scholz H; Schaefer SC; Buettner R; Klein S; Odenthal M
    Mol Cancer Res; 2019 Jun; 17(6):1326-1337. PubMed ID: 30760542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li F; Huang Q; Luster TA; Hu H; Zhang H; Ng WL; Khodadadi-Jamayran A; Wang W; Chen T; Deng J; Ranieri M; Fang Z; Pyon V; Dowling CM; Bagdatlioglu E; Almonte C; Labbe K; Silver H; Rabin AR; Jani K; Tsirigos A; Papagiannakopoulos T; Hammerman PS; Velcheti V; Freeman GJ; Qi J; Miller G; Wong KK
    Cancer Discov; 2020 Feb; 10(2):270-287. PubMed ID: 31744829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes.
    Fang X; Li D; Wan S; Hu J; Zhang P; Jie D; Chen L; Jiang G; Song N
    J Gene Med; 2024 Jun; 26(6):e3694. PubMed ID: 38847309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinase PLK1 promotes the development of
    Kong Y; Allison DB; Zhang Q; He D; Li Y; Mao F; Li C; Li Z; Zhang Y; Wang J; Wang C; Brainson CF; Liu X
    Sci Signal; 2022 Oct; 15(754):eabj4009. PubMed ID: 36194647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
    Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
    Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the role of PLK1 in tumorigenesis by revealing the mutational landscape of colorectal and lung cancer with PLK1 mutations.
    Wang S; Gao F; Bi Y; Zhao X; Ou Q; Zhu M; Wu X; Zhang X; Mao K
    J Cell Mol Med; 2024 Jun; 28(12):e18497. PubMed ID: 38887977
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation.
    Zhu H; Li Q; Zhao Y; Peng H; Guo L; Zhu J; Jiang Z; Zeng Z; Xu B; Chen S
    Oncogene; 2021 Jul; 40(28):4663-4674. PubMed ID: 34140642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    He D; Wang D; Lu P; Yang N; Xue Z; Zhu X; Zhang P; Fan G
    Oncogene; 2021 Jan; 40(2):355-368. PubMed ID: 33144684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100P facilitates LUAD progression via PKA/c-Jun-mediated tumor-associated macrophage recruitment and polarization.
    Gao L; Bai Y; Zhou J; Liang C; Dong Y; Han T; Liu Y; Guo J; Wu J; Hu D
    Cell Signal; 2024 Aug; 120():111179. PubMed ID: 38640980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling.
    Li C; Allison DB; He D; Mao F; Wang X; Rychahou P; Imam IA; Kong Y; Zhang Q; Zhang Y; Liu J; Wang R; Rao X; Wu S; Evers BM; Shao Q; Wang C; Li Z; Liu X
    PLoS Genet; 2023 Nov; 19(11):e1011017. PubMed ID: 37988371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.
    Xu R; Lee YJ; Kim CH; Min GH; Kim YB; Park JW; Kim DH; Kim JH; Yim H
    J Exp Clin Cancer Res; 2023 Nov; 42(1):302. PubMed ID: 37968723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.